Literature DB >> 16762145

Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases.

C A Scirè1, L Cavagna, C Perotti, E Bruschi, R Caporali, C Montecucco.   

Abstract

OBJECTIVE: To determine the usefulness of plasma procalcitonin (PCT) measurement to suspect infectious etiology in febrile patients with systemic autoimmune disease.
METHODS: PCT, C-Reactive protein (CRP), erythrocyte sedimentation rate (ESR) and white blood cell count (WBC) were measured in 44 consecutive inpatients with a diagnosis of systemic autoimmune disease and fever >38 masculine C. After careful microbiologic screening no obvious infection was demonstrated in 24 patients (Group A) while an infectious bacterial complication was diagnosed in 20 cases (Group B).
RESULTS: Median PCT levels were significantly higher in the group B (1.11 vs 0.24 ng/ml; p = 0.0007), whereas the differences for CRP, WBC and ESR did not reach statistical significance. PCT also exhibited a good sensitivity and specificity (75%) in differentiating patients with infection from those with disease flare. With respect to positive and negative predictive values (71.4% and 78.2%), PCT markedly exceeded the other variables. By analyzing PCT values by disease we identified a false positive subgroup of patients suffering from adult onset Still's disease (AOSD), showing markedly elevated PCT levels in absence of infection. By excluding these patients, PCT showed a very good sensitivity and specificity (73.6% and 89.4%) and the area under receiver operating characteristics (ROC) curve rose from 0.801 to 0.904.
CONCLUSION: Our data indicate that elevated PCT concentrations offer good sensitivity and specificity for the diagnosis of systemic bacterial infection in febrile patients with systemic autoimmune diseases. However, in fever associated with AOSD PCT may be elevated even in the absence of infectious complication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762145

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  27 in total

Review 1.  Validation of new biomarkers in systemic autoimmune diseases.

Authors:  Maria G Tektonidou; Michael M Ward
Journal:  Nat Rev Rheumatol       Date:  2011-11-01       Impact factor: 20.543

Review 2.  Use of plasma procalcitonin levels as an adjunct to clinical microbiology.

Authors:  David N Gilbert
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

Review 3.  Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.

Authors:  Ilaria Serio; Laurent Arnaud; Alexis Mathian; Pierre Hausfater; Zahir Amoura
Journal:  Clin Rheumatol       Date:  2014-07-27       Impact factor: 2.980

Review 4.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

5.  Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation.

Authors:  M Sato; H Nakasone; K Terasako-Saito; K Sakamoto; R Yamazaki; Y Tanaka; Y Akahoshi; H Nakano; T Ugai; H Wada; R Yamasaki; Y Ishihara; K Kawamura; M Ashizawa; S-i Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

6.  Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.

Authors:  Yizhi Xiao; Hui Luo; Bin Zhou; Xiaodan Dai; Jing Huang; Liping Duan; Yunhui You; Weiru Zhang; Hongjun Zhao; Yanli Xie; Yaou Zhou; Wangbin Ning; Tong Li; Sijia Liu; Honglin Zhu; Xiaoyun Xie; Ying Jiang; Shiyao Wu; Weijia He; Yisha Li
Journal:  Rheumatol Int       Date:  2016-11-22       Impact factor: 2.631

7.  Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.

Authors:  Paolo Sfriso; Roberta Priori; Guido Valesini; Silvia Rossi; Carlo Maurizio Montecucco; Anna D'Ascanio; Linda Carli; Stefano Bombardieri; Gaetana LaSelva; Florenzo Iannone; Giovanni Lapadula; Stefano Alivernini; Gianfranco Ferraccioli; Michele Colaci; Clodoveo Ferri; Daniela Iacono; Gabriele Valentini; Luisa Costa; Raffaele Scarpa; Andrea LoMonaco; Valentina Bagnari; Marcello Govoni; Ilaria Piazza; Silvano Adami; Francesco Ciccia; Giovanni Triolo; Elisa Alessandri; Maurizio Cutolo; Luca Cantarini; Mauro Galeazzi; Piero Ruscitti; Roberto Giacomelli; Francesco Caso; Paola Galozzi; Leonardo Punzi
Journal:  Clin Rheumatol       Date:  2016-05-20       Impact factor: 2.980

8.  Multi-organ failure in adult onset Still's disease: a septic disguise.

Authors:  Paul R J Ames; Emily Walker; Darren Aw; David Marshall; Francois de Villiers; Manfred Staber
Journal:  Clin Rheumatol       Date:  2008-10-07       Impact factor: 2.980

9.  PCT as a Prognostic Marker in Cardiac Patients with Neutropenic Sepsis: Two Case Reports.

Authors:  Neelima Verma; Shaloo Kapoor; Deepa Rao; Siddhartha Sharma; Anita Arora
Journal:  Indian J Clin Biochem       Date:  2013-10-02

10.  Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  Li-Na Liu; Peng Wang; Shi-Yang Guan; Xiao-Mei Li; Bao-Zhu Li; Rui-Xue Leng; Hai-Feng Pan
Journal:  Rheumatol Int       Date:  2017-10-03       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.